Seattle-based AltPep Corporation raised $23.15 million in a Series A financing round to take the company’s breakthrough amyloid targeting platform to development.
If you are not happy with the results below please do another search
50 search results for:
President-elect Joe Biden’s plan to boost the Covid-19 vaccine rollout – including by spending $20 billion to create mass vaccination centers – should help speed up putting shots into the arms of millions of Americans, experts and officials told Reuters.
As the 2021 virtual J.P. Morgan Healthcare Conference wrapped up, BioSpace reviewed news from companies regarding their deals, pipeline and regulatory updates.
The U.S. Food and Drug Administration approved Pfizer’s Xalkori (crizotinib) for pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma that is anaplastic lymphoma kinase-positive.
Pfizer will temporarily reduce deliveries to Europe of the company’s vaccine against Covid-19 while upgrading production capacity.
AstraZeneca Plc’s cancer drug Imfinzi was approved in Europe and Britain for a spaced-out regimen in a common type of lung cancer to help reduce the frequency of hospital visits while continuing treatment.
Billionaire entrepreneur Mark Cuban – best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank” – is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.
closerlook inc. promoted two members of the digital-native marketing agency’s account team: David Droll and Chelsea Patton.
A drop-off in virulence is possible for the SARS-CoV-2 virus – once enough of the global population has been vaccinated or exposed to it, according to a study from scientists at Emory University and The Pennsylvania State University.
The Pfizer Breakthrough Growth Initiative has invested a total of $120 million into four separate clinical-stage biotech companies.